139 related articles for article (PubMed ID: 18565893)
1. Risk of cancer by ATM missense mutations in the general population.
Dombernowsky SL; Weischer M; Allin KH; Bojesen SE; Tybjaerg-Hansen A; Nordestgaard BG
J Clin Oncol; 2008 Jun; 26(18):3057-62. PubMed ID: 18565893
[TBL] [Abstract][Full Text] [Related]
2. Contribution of mutations in ATM to breast cancer development in the Czech population.
Soukupova J; Dundr P; Kleibl Z; Pohlreich P
Oncol Rep; 2008 Jun; 19(6):1505-10. PubMed ID: 18497957
[TBL] [Abstract][Full Text] [Related]
3. ATM germline mutations in women with familial breast cancer and a relative with haematological malignancy.
Paglia LL; Laugé A; Weber J; Champ J; Cavaciuti E; Russo A; Viovy JL; Stoppa-Lyonnet D
Breast Cancer Res Treat; 2010 Jan; 119(2):443-52. PubMed ID: 19404735
[TBL] [Abstract][Full Text] [Related]
4. ATM missense variant P1054R predisposes to prostate cancer.
Meyer A; Wilhelm B; Dörk T; Bremer M; Baumann R; Karstens JH; Machtens S
Radiother Oncol; 2007 Jun; 83(3):283-8. PubMed ID: 17502119
[TBL] [Abstract][Full Text] [Related]
5. Increased risk of breast cancer associated with CHEK2*1100delC.
Weischer M; Bojesen SE; Tybjaerg-Hansen A; Axelsson CK; Nordestgaard BG
J Clin Oncol; 2007 Jan; 25(1):57-63. PubMed ID: 16880452
[TBL] [Abstract][Full Text] [Related]
6. Cancer risk according to type and location of ATM mutation in ataxia-telangiectasia families.
Cavaciuti E; Laugé A; Janin N; Ossian K; Hall J; Stoppa-Lyonnet D; Andrieu N
Genes Chromosomes Cancer; 2005 Jan; 42(1):1-9. PubMed ID: 15390180
[TBL] [Abstract][Full Text] [Related]
7. Spectrum of ATM gene mutations in a hospital-based series of unselected breast cancer patients.
Dörk T; Bendix R; Bremer M; Rades D; Klöpper K; Nicke M; Skawran B; Hector A; Yamini P; Steinmann D; Weise S; Stuhrmann M; Karstens JH
Cancer Res; 2001 Oct; 61(20):7608-15. PubMed ID: 11606401
[TBL] [Abstract][Full Text] [Related]
8. ATM variants and cancer risk in breast cancer patients from Southern Finland.
Tommiska J; Jansen L; Kilpivaara O; Edvardsen H; Kristensen V; Tamminen A; Aittomäki K; Blomqvist C; Børresen-Dale AL; Nevanlinna H
BMC Cancer; 2006 Aug; 6():209. PubMed ID: 16914028
[TBL] [Abstract][Full Text] [Related]
9. ATM and breast cancer susceptibility.
Ahmed M; Rahman N
Oncogene; 2006 Sep; 25(43):5906-11. PubMed ID: 16998505
[TBL] [Abstract][Full Text] [Related]
10. The spectrum of ATM missense variants and their contribution to contralateral breast cancer.
Broeks A; Braaf LM; Huseinovic A; Schmidt MK; Russell NS; van Leeuwen FE; Hogervorst FB; Van 't Veer LJ
Breast Cancer Res Treat; 2008 Jan; 107(2):243-8. PubMed ID: 17393301
[TBL] [Abstract][Full Text] [Related]
11. ATM germline mutations in Spanish early-onset breast cancer patients negative for BRCA1/BRCA2 mutations.
Brunet J; Gutiérrez-Enríquez S; Torres A; Bérez V; Sanjosé S; Galceran J; Izquierdo A; Menéndez JA; Gumà J; Borràs J
Clin Genet; 2008 May; 73(5):465-73. PubMed ID: 18384426
[TBL] [Abstract][Full Text] [Related]
12. Atm-haploinsufficiency enhances susceptibility to carcinogen-induced mammary tumors.
Lu S; Shen K; Wang Y; Santner SJ; Chen J; Brooks SC; Wang YA
Carcinogenesis; 2006 Apr; 27(4):848-55. PubMed ID: 16400190
[TBL] [Abstract][Full Text] [Related]
13. Lack of association between ATM C.1066-6T > G mutation and breast cancer risk: a meta-analysis of 8,831 cases and 4,957 controls.
Ding H; Mao C; Li SM; Liu Q; Lin L; Chen Q
Breast Cancer Res Treat; 2011 Jan; 125(2):473-7. PubMed ID: 20544271
[TBL] [Abstract][Full Text] [Related]
14. Two ATM variants and breast cancer risk.
Thompson D; Antoniou AC; Jenkins M; Marsh A; Chen X; Wayne T; Tesoriero A; Milne R; Spurdle A; Thorstenson Y; Southey M; Giles GG; Khanna KK; Sambrook J; Oefner P; Goldgar D; Hopper JL; Easton D; Chenevix-Trench G;
Hum Mutat; 2005 Jun; 25(6):594-5. PubMed ID: 15880680
[TBL] [Abstract][Full Text] [Related]
15. Effect of CHEK2 missense variant I157T on the risk of breast cancer in carriers of other CHEK2 or BRCA1 mutations.
Cybulski C; Górski B; Huzarski T; Byrski T; Gronwald J; Debniak T; Wokolorczyk D; Jakubowska A; Serrano-Fernández P; Dork T; Narod SA; Lubinski J
J Med Genet; 2009 Feb; 46(2):132-5. PubMed ID: 18930998
[TBL] [Abstract][Full Text] [Related]
16. A nonsense mutation (E1978X) in the ATM gene is associated with breast cancer.
Bogdanova N; Cybulski C; Bermisheva M; Datsyuk I; Yamini P; Hillemanns P; Antonenkova NN; Khusnutdinova E; Lubinski J; Dörk T
Breast Cancer Res Treat; 2009 Nov; 118(1):207-11. PubMed ID: 18807267
[TBL] [Abstract][Full Text] [Related]
17. Missense mutations but not allelic variants alter the function of ATM by dominant interference in patients with breast cancer.
Scott SP; Bendix R; Chen P; Clark R; Dork T; Lavin MF
Proc Natl Acad Sci U S A; 2002 Jan; 99(2):925-30. PubMed ID: 11805335
[TBL] [Abstract][Full Text] [Related]
18. Histopathological features of breast cancer in carriers of ATM gene variants.
Balleine RL; Murali R; Bilous AM; Farshid G; Waring P; Provan P; Byth K; Thorne H; ; Kirk JA
Histopathology; 2006 Nov; 49(5):523-32. PubMed ID: 17064299
[TBL] [Abstract][Full Text] [Related]
19. [Ataxia-telangiectasia mutated gene and breast cancer susceptibility].
Zhang N; Che J; Bai S; Wu Z; Cui Y; Zou W
Sheng Wu Gong Cheng Xue Bao; 2010 Jan; 26(1):9-15. PubMed ID: 20353086
[TBL] [Abstract][Full Text] [Related]
20. Cancer risks and mortality in heterozygous ATM mutation carriers.
Thompson D; Duedal S; Kirner J; McGuffog L; Last J; Reiman A; Byrd P; Taylor M; Easton DF
J Natl Cancer Inst; 2005 Jun; 97(11):813-22. PubMed ID: 15928302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
